Abbott Laboratories received a scolding from the U.S. Federal Trade Commission on Thursday for paying another drug maker to keep a generic version of its hypertension drug, Hytrin, off the market. The consent order approved by the commission Thursday includes…
Another FDA regulation was struck down by the U.S. district court in Washington, this time covering the approval process for generic drugs.
Under the law, the first manufacturer to seek approval of a generic drug from the FDA gets a 180-day period of exclusive rig…
The Federal Trade Commissions suit filed last month alleging anticompetitive practices by Aventis and Andrx Corp. is part of a larger year-long investigation involving six drugs poised to lose patent protection.
The FTC suit charges that Hoechst, now Aventis, and Andrx entered an…
Teva Pharmaceuticals USA has introduced Terazosin HCl capsules, 1 mg, 2 mg, 5 mg and 10 mg. The product, indicated for treatment of benign prostatic hyperplasia as well as hypertension, is bioequivalent to and therapeutically interchangeable with Hytrin (terazosin HCl) capsules. All capsule strengths are available in bottles of 100.
Most Popular
Public Speaking: 7 Secrets Of Great Publ…
The Capital-Journal
Kansas consumers who purchased the brand name prescription medication Hytrin are eligible for refunds from a $30.7 million nationwide settlement announced Friday.
The refunds to consumers and third-party payers in 18 states will be paid by two companies that, according to the antitrust complaint, had conspired to engage in anticompetitive conduct that delayed the availability of a more affordable generic version of the medication.
Hytrin…
A large government-sponsored trial was stopped recently because participants taking the antihypertensive drug doxazosin were found to be at significantly higher risk for developing congestive heart failure and other cardiovascular problems than those taking an older antihypertensive, the diuretic chlorthalidone. Doxazosin is sold under the brand name, Cardura, and the diuretic used in the trial w…
By Marsha Austin, The Denver Post Knight Ridder/Tribune Business News
Sep. 28–Colorado filed suit Thursday against three major drug manufacturers, including Broomfield-based Geneva Pharmaceuticals, charging them with antitrust violations that kept cheaper generic versions of the drug Hytrin o…
TorPharm’s abbreviated new drug application for a generic form of Hytrin (terazosin HCl), an Abbott drug used for the treatment of high blood pressure and benign prostatic hyperplasia, or BPH, received FDA approval. TorPharm will market the drug in 1 mg, 5 mg and 10 mg strengths.
Related Results
Boehringer…
